Sarepta stock falls on FDA gene therapy Elevidys comment

0 Comments

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The […]


Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

0 Comments

Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]


Online Therapy Boom Has Mainly Benefited Privileged Groups, Studies Find

0 Comments

The number of Americans receiving psychotherapy increased by 30 percent during the pandemic, as virtual sessions replaced in-person appointments — but new research dampens the hope that technology will make mental health care more available to the neediest populations. In fact, the researchers found, the shift to teletherapy has exacerbated existing disparities. The increase in […]